Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1700 participants.
Also called NCT07164859
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,700 participants
- Sponsor
- Vincent ROULE
- Registry
-
NCT07164859 -
2023-507545-28-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT07164859. Randomized; single masking; primary purpose treatment. Start 2026-03-03 (actual); primary completion 2029-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI
- Acronym
- SOLOPCI
- Condition
- Antiplatelet Therapy
- Condition
- Elderly (People Aged 65 or More)
- Intervention (Drug)
- short dual antiplatelet therapy (DAPT) duration
- Intervention (Drug)
- Standard DAPT duration
- Lead sponsor
- Vincent ROULE
Record details
- Record id
cardio:ct-nct07164859- Content hash
a2bcf358698f8b3ca5e398c525e33edda753ae27bc31a123ff04922f2f415ce5